"Staphylococcus aureus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
| Descriptor ID |
D013211
|
| MeSH Number(s) |
B03.300.390.400.800.750.100 B03.353.500.750.750.100 B03.510.100.750.750.100 B03.510.400.790.750.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Staphylococcus aureus".
Below are MeSH descriptors whose meaning is more specific than "Staphylococcus aureus".
This graph shows the total number of publications written about "Staphylococcus aureus" by people in this website by year, and whether "Staphylococcus aureus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 1 | 3 | 4 |
| 1996 | 0 | 1 | 1 |
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 3 | 0 | 3 |
| 2001 | 1 | 1 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 2 | 1 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 3 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 2 | 4 |
| 2012 | 1 | 5 | 6 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 2 | 3 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 1 | 3 |
| 2020 | 2 | 2 | 4 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Staphylococcus aureus" by people in Profiles.
-
The Role of C-X-C Chemokines in Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2023 Mar 01; 64(3):10.
-
Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia. Int J Antimicrob Agents. 2023 Apr; 61(4):106752.
-
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel. Int J Antimicrob Agents. 2023 Apr; 61(4):106743.
-
Non-Antibiotic Antimony-Based Antimicrobials. Molecules. 2022 Oct 23; 27(21).
-
Prompt Recognition of Hemophagocytic Lymphohistiocytosis in an Afebrile Patient with Lupus and Staphylococcus aureus Bacteremia. Am J Case Rep. 2021 Nov 09; 22:e934092.
-
Neonatal Toxic Shock Syndrome-Like Exanthematous Disease in North America. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):205-206.
-
Empiric Antibiotic Therapy for Staphylococcus aureus Septic Shock: Is Vancomycin Indicated? Crit Care Med. 2020 12; 48(12):e1370-e1371.
-
Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains. Appl Microbiol Biotechnol. 2020 Sep; 104(18):7853-7865.
-
Inhibitor design to target a unique feature in the folate pocket of Staphylococcus aureus dihydrofolate reductase. Eur J Med Chem. 2020 Aug 15; 200:112412.
-
Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance. PLoS Pathog. 2020 03; 16(3):e1008354.